The telmisartan market is also driven by the increasing adoption of telmisartan as a first-line treatment for hypertension and other cardiovascular conditions. Telmisartan is often prescribed as a first-line treatment due to its efficacy, tolerability, and safety profile. In addition, telmisartan has a long duration of action, which allows for once-daily dosing, improving patient adherence to treatment.
However, the Telmisartan Market is also facing some challenges. One of the main challenges is the availability of generic versions of telmisartan, which can be cheaper than the branded version. The availability of generic versions of telmisartan can lead to price erosion and reduce revenue for branded manufacturers. In addition, the increasing use of generic versions of telmisartan can also affect the quality of the drug, as some generic versions may not meet the same quality standards as the branded version.
Despite these challenges, the telmisartan market is expected to continue to grow, driven by the need for effective and safe treatments for hypertension and other cardiovascular conditions. The primary demand driver for Telmisartan is the increasing prevalence of hypertension and cardiovascular diseases worldwide. According to the World Health Organization (WHO), hypertension affects around 1.13 billion people worldwide, and this number is expected to increase to 1.5 billion by 2025. Hypertension is a major risk factor for cardiovascular diseases, which are the leading cause of death worldwide.
Read more @ https://creativeedge16.blogspot.com/2023/03/telmisartan-market-global-outlook.html
